These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39011654)

  • 61. Proteomic Analysis of Blood Extracellular Vesicles in Cardiovascular Disease by LC-MS/MS Analysis.
    Baldan-Martin M; de la Cuesta F; Alvarez-Llamas G; Ruiz-Hurtado G; Ruilope LM; Barderas MG
    Methods Mol Biol; 2017; 1619():141-149. PubMed ID: 28674883
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
    Hallal S; Azimi A; Wei H; Ho N; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635403
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography-mass spectrometry.
    Passos-Castilho AM; Carvalho VM; Cardozo KH; Kikuchi L; Chagas AL; Gomes-Gouvêa MS; Malta F; de Seixas-Santos Nastri AC; Pinho JR; Carrilho FJ; Granato CF
    BMC Cancer; 2015 Dec; 15():985. PubMed ID: 26680993
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development of quantitative plasma N-glycoproteomics using label-free 2-D LC-MALDI MS and its applicability for biomarker discovery in hepatocellular carcinoma.
    Ishihara T; Fukuda I; Morita A; Takinami Y; Okamoto H; Nishimura S; Numata Y
    J Proteomics; 2011 Sep; 74(10):2159-68. PubMed ID: 21704746
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Omega-6-derived oxylipin changes in serum of patients with hepatitis B virus-related liver diseases.
    Lu Y; Fang J; Zou L; Cui L; Liang X; Lim SG; Dan YY; Ong CN
    Metabolomics; 2018 Jan; 14(3):26. PubMed ID: 30830341
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
    Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
    Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Proteomic landscape of extracellular vesicles in human retinal cells infected with Staphylococcus aureus and Pseudomonas aeruginosa: Role in endophthalmitis.
    Rudraprasad D; Joseph J
    Exp Cell Res; 2023 Jun; 427(2):113604. PubMed ID: 37075825
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.
    Cai X; Peng S; Xiao X; Huang Z; Zhang P
    Sci Rep; 2024 May; 14(1):10996. PubMed ID: 38744926
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Untargeted metabolomics of blood plasma samples of patients with hepatocellular carcinoma.
    Böhmová A; Mikoška M; Syslová K; Šindelářová D; Hříbek P; Urbánek P; Setnička V
    J Pharm Biomed Anal; 2024 Sep; 248():116263. PubMed ID: 38852296
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma.
    Yang L; Rong W; Xiao T; Zhang Y; Xu B; Liu Y; Wang L; Wu F; Qi J; Zhao X; Wang H; Han N; Guo S; Wu J; Gao Y; Cheng S
    Sci China Life Sci; 2013 Jul; 56(7):638-46. PubMed ID: 23749381
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma.
    Ahn YH; Shin PM; Oh NR; Park GW; Kim H; Yoo JS
    J Proteomics; 2012 Sep; 75(17):5507-15. PubMed ID: 22789673
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to α fetoprotein.
    Shu H; Kang X; Guo K; Li S; Li M; Sun L; Gan L; Liu Y; Qin X
    Oncol Rep; 2010 Nov; 24(5):1271-6. PubMed ID: 20878120
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus.
    Abdel Wahab AHA; El-Halawany MS; Emam AA; Elfiky A; Abd Elmageed ZY
    Biomarkers; 2017 Nov; 22(7):621-628. PubMed ID: 27788588
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease].
    Zhao Y; Liu X; Zhang Y; Zhang J; Liu X; Yang G
    Se Pu; 2023 Dec; 41(12):1073-1083. PubMed ID: 38093537
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC-MS/MS.
    Baniasadi H; Gowda GA; Gu H; Zeng A; Zhuang S; Skill N; Maluccio M; Raftery D
    Electrophoresis; 2013 Oct; 34(19):2910-7. PubMed ID: 23856972
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 2-D DIGE.
    Ferrín G; Ranchal I; Llamoza C; Rodríguez-Perálvarez ML; Romero-Ruiz A; Aguilar-Melero P; López-Cillero P; Briceño J; Muntané J; Montero-Álvarez JL; De la Mata M
    Liver Int; 2014 Mar; 34(3):438-46. PubMed ID: 23944848
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC/IT-TOF MS.
    Chen S; Yin P; Zhao X; Xing W; Hu C; Zhou L; Xu G
    Electrophoresis; 2013 Oct; 34(19):2848-56. PubMed ID: 24228263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.